Journey Advisory Group LLC Purchases 2,104 Shares of CME Group Inc. $CME

Journey Advisory Group LLC increased its position in CME Group Inc. (NASDAQ:CME) by 19.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,908 shares of the financial services provider’s stock after acquiring an additional 2,104 shares during the quarter. Journey Advisory Group LLC’s holdings in CME Group were worth $3,558,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Heartland Bank & Trust Co bought a new position in CME Group in the 1st quarter worth $377,000. Catalyst Capital Advisors LLC raised its holdings in CME Group by 256.9% in the 1st quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider’s stock worth $971,000 after acquiring an additional 2,636 shares during the period. OMNI 360 Wealth Inc. bought a new position in CME Group in the 1st quarter worth $367,000. Fulcrum Equity Management bought a new position in CME Group in the 1st quarter worth $258,000. Finally, AIA Group Ltd raised its holdings in CME Group by 17.8% in the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider’s stock worth $4,416,000 after acquiring an additional 2,510 shares during the period. Institutional investors own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on CME. TD Cowen lifted their target price on shares of CME Group from $281.00 to $288.00 and gave the stock a “hold” rating in a report on Wednesday, October 8th. Jefferies Financial Group dropped their price objective on shares of CME Group from $313.00 to $304.00 and set a “buy” rating on the stock in a report on Friday, October 10th. Barclays dropped their price objective on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of CME Group from $276.00 to $266.00 and set a “hold” rating on the stock in a report on Thursday, October 9th. Finally, Keefe, Bruyette & Woods boosted their price objective on shares of CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a report on Monday, October 13th. Seven analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $283.71.

Insider Buying and Selling at CME Group

In other news, insider Timothy Francis Mccourt sold 379 shares of CME Group stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the sale, the insider directly owned 9,508 shares in the company, valued at approximately $2,470,463.64. The trade was a 3.83% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, General Counsel Jonathan L. Marcus sold 392 shares of the business’s stock in a transaction dated Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the transaction, the general counsel owned 7,851 shares in the company, valued at approximately $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,043 shares of company stock valued at $3,527,956 in the last 90 days. Insiders own 0.30% of the company’s stock.

CME Group Price Performance

Shares of CME Group stock opened at $267.93 on Monday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The firm’s 50-day simple moving average is $267.30 and its 200-day simple moving average is $271.40. CME Group Inc. has a twelve month low of $213.94 and a twelve month high of $290.79. The firm has a market cap of $96.56 billion, a P/E ratio of 25.94, a price-to-earnings-growth ratio of 6.16 and a beta of 0.41.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the previous year, the business earned $2.56 EPS. The firm’s revenue was up 10.4% on a year-over-year basis. As a group, research analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s payout ratio is 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.